Filing Flows › OptimizeRx (OPRX) › Q1 2026 › vs Q4 2025
OptimizeRx (OPRX) Q1 2026 vs Q4 2025 (quarter over quarter)
OptimizeRx's revenue fell $12.4M (-38%) from $32.2M in Q4 2025 to $19.8M in Q1 2026.
OptimizeRx, Q1 2026: revenue $19.8M (-10% year over year), operating margin 2.0%, net loss $495K, operating cash flow −$467K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $19.8M | $32.2M | −$12.4M | -38% |
| Income tax benefit | $149K | −$2.5M | $2.6M | — |
| Net loss | $495K | −$5.0M | $5.5M | — |
| Costs & expenses | $20.5M | $32.2M | −$11.8M | -36% |
| Operating costs | $19.4M | $23.7M | −$4.2M | -18% |
| Interest & other, net | $1.0M | $1.1M | −$58K | -5% |
| Operating cash sources | $3.4M | −$4.0M | $7.4M | — |
| Depreciation & amortization | $1.1M | $1.1M | −$14K | -1% |
| Share-based compensation | $1.8M | $2.0M | −$132K | -7% |
| Cash used in operations | $467K | −$7.1M | $7.6M | — |
| Net loss absorbed | $495K | −$5.0M | $5.5M | — |
| Working capital & other | $2.9M | $970K | $1.9M | +195% |
Questions
How much did OptimizeRx's revenue grow quarter over quarter in Q1 2026?
OptimizeRx's revenue fell $12.4M (-38%) from $32.2M in Q4 2025 to $19.8M in Q1 2026.